316. Carnitine cycle disorder Clinical trials / Disease details
Clinical trials : 4 / Drugs : 10 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 11
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02226419 (ClinicalTrials.gov) | August 2013 | 5/8/2013 | Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency | Fat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter Deficiency | Carnitine Transporter, Plasma-membrane, Deficiency of | Dietary Supplement: Break in L-carnitine treatment | Karen Lindhardt Madsen | Rigshospitalet, Denmark | Completed | 18 Years | N/A | Both | 14 | N/A | NULL |